Paolo Zamboni

A long-awaited study into Paolo Zamboni’s treatment yields disappointment for most sufferers—yet hope of relief for a few

Results from a key Canadian study into venoplasty for MS appear to have been prematurely released, leaving questions

Internal documents show why Canada has not kept its promise to accelerate contentious clinical trials for MS

Brad Wall: ’It’s a good day in the province of Saskatchewan’

MS drugs get fast-tracked all the time. Why can’t a clinical trial get the same treatment?

Zamboni’s research almost certainly has to have been junk

Private member’s bill would see federal government fund clinical trials of controversial treatment

Experts and journalists are reading whatever they want into a new study examining CCSVI in MS patients

COSH: "There’s no unitary global Science Court where hypotheses can be hauled in for exoneration or hanging"